X

Polar Pharma India Ltd Stock Analysis

Small Cap
Evaluated by 71 users | BSE: 523333 | NSE: |
Rubber Products
Polar Pharma India, earlier known as ‘Palar Latex Ltd, was launched in the year 1988 and starterd the commercial production from its Balasore plant in 1991.The company is committed to better, safer, more enjoyable life for the people. A company where people and technology continuously...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12
Return on Capital Employed 3.13%7.25%0.36%-10.71%-6.22%3.03%-110.18%-38.68%-19.38%-42.79%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 49.143.335.24618.925.90.3010.916.2
Y-o-Y Gr. Rt.--11.8%-18.8%30.9%-59%37%-99%-88.5%36266.7%48.5%
Adjusted EPS (Rs.) 0.020.13-4.43-6.77-5.3-1.84-30.45-13.09-11-15.41
Y-o-Y Gr. Rt.-550%-3507.7%NANANANANANANA
Book Value per Share (Rs.) 6.246.632.69.062.880.8-54.56-67.67-78.7-94.1
Adjusted Net Profit 00.2-5.3-8.3-6.5-2.3-37.4-16.1-13.5-18.9
Net Op. Cash Flow (Rs. Cr.) 3.6-0.43.820.5-6.46.1-40.52.4-0.90.7
Debt to Cash Flow from Ops 14.56-138.1514.761.93-76.81-2.0943.04-128.02194.4
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Polar Pharma India Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -11.6%-3%296.4%48.5%
Adjusted EPS -309.3%NANANA
Book Value per Share -235.2-300.800
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12
Return on Equity (%) 0.221.42-66.95-92.25-74.11-64.2117.7621.7915.2518.05
Operating Profit Margin (%) 5.9514.8710.45-13.65-21.271.04-4123.74-7462.1217.61-12.5
Net Profit Margin (%) 0.050.35-15.07-18.06-34.48-8.71-14530.6-58751.38-123.74-116.74
Debt to Equity 6.055.9412.773.29.3918.64-1.29-1.26-1.23-1.16
Working Capital Days 21524829523055228114,04367,295223134
Cash Conversion Cycle 1301562031744452107,4687,812424
Entity Percentage Holding
Promoters 29.75%
Institutions 2.64%
Non-Institutions 67.62%
Pledged *93.9393.9393.9393.9393.9393.9393.9393.9393.9393.93
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Polar Pharma India, earlier known as ‘Palar Latex Ltd, was launched in the year 1988 and starterd the commercial production from its Balasore plant in 1991.

The company is committed to better, safer, more enjoyable life for the people. A company where people and technology continuously work hand in hand to evolve new standards of excellence in the field of male prophylactics. Where business values are re-defined with greater, global social concerns in mind. And the concern is turned

Polar Pharma India, earlier known as ‘Palar Latex Ltd, was launched in the year 1988 and starterd the commercial production from its Balasore plant in 1991.

The company is committed to better, safer, more enjoyable life for the people. A company where people and technology continuously work hand in hand to evolve new standards of excellence in the field of male prophylactics. Where business values are re-defined with greater, global social concerns in mind. And the concern is turned into an action point in the company’s mission statement itself.

Today, Polar Pharma enjoys worldwide popularity and trust, as the key producer of high quality, male latex prophylactics in India. In fact, the company is one of the largest private sector condom manufacturing units in Asia, with an installed capacity of over 700 million pieces per annum.

A qualified team of professionals conduct regular checks for every batch produced to ensure consistency and quality of the finished products. PPIL has an in-house fully equipped product testing laboratory for quality checks

Product range of the company includes:

Contraceptives – condoms of the following types:

  • Adam- Lubricated Condoms
  • Seorita
  • Moments- Premium Condoms

Achievements/ recognition :

  • The company’s quality System has ISO:9001 accreditation received in the year 2000. and ISO 14001
  • The company has also received CE Certification in the year 2003.
  • Capexil Awards 2000-2001, 2002-2003 & 2005-2006
  • Capexil Certificate 
  • Star House Awards
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback